Influence of peroxisome proliferator-activated receptor γ activation by its endogenous ligand 15-deoxy Δ 1214 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women

Molecular Human Reproduction

Volumn 10, Issue 9, 2004, Pages 671-676

  Jawerbaum, A ^a   Capobianco, E ^a   Pustovrh, C ^a   White, V ^a   Baier, M ^b   Salzberg, S ^b   Pesaresi, M ^b   Gonzalez, E ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

^b HOSPITAL DURAND   (Argentina)

Author keywords

15dPGJ2; Diabetes; Nitric oxide; Placenta; PPAR

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; INSULIN; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOCYTE; ARTICLE; CELL INVASION; CELL PROLIFERATION; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; EXPLANT; FEMALE; FETUS OUTCOME; GESTATION PERIOD; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; PLACENTA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TISSUE DIFFERENTIATION; TROPHOBLAST;

BIOLOGICAL RESPONSE MODIFIERS; DIABETES MELLITUS, TYPE 1; DIABETES, GESTATIONAL; FEMALE; HUMANS; NITRATES; NITRIC OXIDE; NITRITES; PLACENTA; PPAR GAMMA; PREGNANCY; PREGNANCY IN DIABETICS; PROSTAGLANDIN D2;

EID: 5044245034     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/gah090     Document Type: Article

References (40)

1. Aerts L and Van Assche FA (2003) Intra-uterine transmission of disease. Placenta 24,905-911.
2. Ahmed A and Perkins J (2000) Angiogenesis and intrauterine growth restriction. Baillières Best Pract Res Clin Obstet Gynaecol 14,981-998.
3. Asociación Latinoamericana de Diabetes (ALAD) (1997) Consenso sobre la atención a la embarazada con diabetes. Rev Asoc Latin Diabetes 5, 223-234.
4. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A and Evans RM (1999) PPARgamma is required for placental, cardiac and adipose tissue development. Mol Cell 4,585-595.
5. Barker DJP (1999) Fetal programming and public health. In Wheeler T and Barker DJP (eds) Programming Influences of Development and Diseases in Later Life. RCOG Press, London, UK, pp. 156-202.
6. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72,248-254.
7. Clarson C, Tevaarwerk GJ, Harding PG, Chance GW and Haust MD (1989) Placental weight in diabetic pregnancies. Placenta 10,275-281.
8. Coughlan MT, Oliva K, Georgiou HM, Permezel JM and Rice GE (2001) Glucose-induced release of tumour necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus. Diabet Med 18,921-927.
9. Desoye G, Hauguel de-Mouzon S and Shafrir E (2003) The human placenta in diabetes. In Hod M, Jovanovich L, DiRenzo S, deLeiva A, and Langer O (eds) Textbook of Diabetic Pregnancy. Dunitz Ltd, London, UK, pp. 126-147.
10. Diamant YZ, Metzger BE, Freinkel N and Shafrir E (1982) Placental lipid and glycogen content in human and experimental diabetes mellitus. Am J Obstet Gynecol 144,5-11.
11. Di Iulio JL, Gude NM, King RG, Li CG, Rand MJ and Brennecke SP (1999) Human placental nitric oxide synthase activity is not altered in diabetes. Clin Sci (Lond) 97,123-128.
12. Figueroa R, Martínez E, Fayngersh RP, Tejani N, Mohazzab-H KM and Wolin MS (2000) Alterations in relaxation to lactate and H(2)O(2) in human placental vessels from gestational diabetic pregnancies. Am J Physiol Heart Circ Physiol 278,H706-H713.
13. González E, Jawebaum A, Sinner D, Pustovrh C, White V, Capobianco E, Xaus C, Peralta C and Roselló-Catafau J (2001) Streptozotocin-pancreatic damage in the rat: modulatory effect of 15-deoxy delta 12,14 prostaglandin J2 on nitridergic and prostanoid pathway. Nitric Oxide 6,1-8.
14. 15N] nitrate in biological fluids. Anal Biochem 126,131-138.
15. Hammer A, Desoye G, Dohr G, Sattler W and Malle E (2001) Myeloperoxidase-dependent generation of hypochlorite-modified proteins in human placental tissues during normal pregnancy. Lab Invest 81, 543-554.
16. Herrera E, Martin A, Palacin M and Lasuncion M (1986) Placental modifications of transferred maternal substrates in normal and diabetic rats. In Serrano-Ríos M and Lefebre PJ (eds) Diabetes 1985. Excerpta Medica, Amsterdam, pp. 570-574.
17. Jawerbaum A, Sinner D, White V, Pustovrh C, Capobianco E and González E (2002) 15deoxy delta12,14PGJ2 modulates nitric oxide levels and lipid metabolism in embryos from control and diabetic rats during early organogenesis. Reproduction 124, 625-631.
18. Kinalski M, Sledziewski A, Telejko B, Kowalska I, Kretowski A, Zarzycki W and Kinalska I (2001) Lipid peroxidation, antioxidant defence and acid-base status in cord blood at birth: the influence of diabetes. Horm Metab Res 33,227-231.
19. Kliewer SA, Forman BM, Blumbert B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umeson OK and Evans RM (1994) Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91,7355-7359.
20. Kossenjans W, Eis A, Sahay R, Brockman D and Myatt L (2000) Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia. Am J Physiol Heart Circ Physiol 278,H1311-H1319.
21. Kuhn DC, Crawford MA, Stuart MJ, Botti JJ and Demers LM (1990a) Alterations in transfer and lipid distribution of arachidonic acid in placentas of diabetic pregnancies. Diabetes 39,914-918.
22. Kuhn DC, Botti JJ, Cherouny PH and Demers LM (1990b) Eicosanoid production and transfer in the placenta of the diabetic pregnancy. Prostaglandins 40,205-215.
23. Lyall F, Gibson JL, Greer IA, Brockman DE, Eis AL and Myatt L (1998) Increased nitrotyrosine in the diabetic placenta: evidence for oxidative stress. Diabetes Care 21,1753-1758.
24. Mayhew TM, Sorensen FB, Klebe JG and Jackson MR (1994) Growth and maturation of villi in placentae from well-controlled diabetic women. Placenta 15,57-65.
25. Novaro, V, Colman-Lerner A, Ortega FV, Jawerbaum A, Paz D, Lo Nostro F, Pustovrh C, Gimeno MF and González E (2001) Regulation of metalloproteinases by nitric oxide in human trophoblast cell in culture. Reprod Fertil Dev 13,411-420.
26. Piconi L, Quagliaro L and Ceriello A (2003) Oxidative stress in diabetes. Clin Chem Lab Med 41,1144-1149.
27. Pustovrh C, Jawerbaum A, Sinner D, Pesaresi M, Baier M, Gimeno M and Gonzalez E (2000) Membrane-type matrix metalloproteinase-9 activity in placental tissue from patients with pregestational and gestational diabetes mellitus. Reprod Fertil Dev 12,269-275.
28. Resnik R (1983) Endocrine modulation of uterine blood flow in pregnancy. Clin Perinatol 10,567-573.
29. Ricote M, Li AC, Willson TM, Kelly CJ and Glass CK (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391,79-82.
30. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M and Santoro MG (2000) Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403,103-108.
31. Rossmanith WG, Hoffmeister U, Wolfahrt S, Kleine B, McLean M, Jacobs RA and Grossman AB (1999) Expression and functional analysis of endothelial nitric oxide synthase (eNOS) in human placenta. Mol Hum Reprod 5,487-494.
32. Saldeen P, Olofsson P and Laurini RN (2002) Structural, functional and circulatory placental changes associated with impaired glucose metabolism. Eur J Obstet Gynecol Reprod Biol 105,136-142.
33. Schonfelder G, John M, Hopp H, Fuhr N, van Der Giet M and Paul M (1996) Expression of inducible nitric oxide synthase in placenta of women with gestational diabetes. FASEB J 10,777-784.
34. Shibata T, Kondo M, Osawa T, Shibata N, Kobayashi M and Uchida K (2002) 15-deoxy-delta 12, 14-prostaglandin J2: a prostaglandin D2 metabolite generated during inflammatory processes. J Biol Chem 277,10459-10466.
35. Strauss DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G and Glass CK (2000) 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci USA 97,4844-4849.
36. Szabo C (2003) Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 140-141,105-112.
37. White V, Jawerbaum A, Sinner D, Pustovrh C, Capobianco E and González E (2002) Oxidative stress and altered prostanoid production in the placenta of streptozotocin-induced diabetic rats. Reprod Fertil Dev 14,117-123.
38. Winick M and Noble A (1967) Cellular growth in human placenta II diabetes mellitus. J Pediatr 71,216-219.
39. Yang ZZ, Tschopp O, Hemmings-Mieszczak M, Feng J, Brodbeck D, Perentes E and Hemmings BA (2003) Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J Biol Chem 278, 32124-32131.
40. Younes B, Baez Giangreco A, al Nuaim L, al Hakeem A and Abu Talib Z (1996) Basement membrane thickening in the placentae from diabetic women. Pathol Int 46,100-104.